Projects funded by the NCN
Glaucoma neuroprotection with BDNF on the level of retinal and primary visual cortex
2016/23/N/NZ7/02555
Keywords:
galucoma BDNF neuroprotection adeno-associated viral vector AAV visual system retina
Descriptors:
- NZ7_4: Prevention in population health
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 12 - announced on 2016-09-15
Amount awarded: 150 000 PLN
Project start date (Y-m-d): 2017-08-29
Project end date (Y-m-d): 2021-02-27
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- 55-calowy monitor z zakrzywionym ekranem typu OLED (7 200 PLN)
Information in the final report
- Publication in academic press/journals (1)
- Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in GlaucomaAuthors:Anna Wójcik-Gryciuk, Olga Gajewska-Woźniak, Katarzyna Kordecka, Paweł M. Boguszewski, Wioletta Waleszczyk, Małgorzata SkupAcademic press:International Journal of Molecular Sciences (rok: 2020, tom: 17, strony: 15), Wydawca: MDPIStatus:PublishedDOI:10.3390/ijms21176262 - link to the publication